+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bacteriological Testing Market by Application, Technology, End User, Sample Type, Organism Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989840
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bacteriological Testing Market grew from USD 12.54 billion in 2024 to USD 13.93 billion in 2025. It is expected to continue growing at a CAGR of 10.82%, reaching USD 23.23 billion by 2030.

Introduction to a New Era in Bacteriological Testing

The bacteriological testing sector has emerged as a cornerstone of public health, food safety, environmental stewardship, and pharmaceutical quality assurance. In recent years, the confluence of technological breakthroughs, shifting regulatory frameworks, and heightened awareness of microbial threats has propelled the market onto a trajectory of rapid evolution. Stakeholders across laboratories, clinical institutions, and industrial settings are now navigating a complex ecosystem where precision, speed, and cost-effectiveness define competitive advantage.

Against this backdrop, laboratories are transitioning from traditional culture-based methods toward integrated molecular and digital solutions. This shift reflects an industry imperative to detect pathogens with greater sensitivity, trace contamination in real time, and comply with stringent global standards. Decision-makers require an in-depth understanding of these dynamics to align investments with emerging opportunities and to ensure resilient operations. This executive summary offers a panoramic view of the critical forces shaping bacteriological testing today, equipping professionals with the insights needed to chart a confident course in an increasingly complex market.

Emerging Forces Reshaping the Testing Ecosystem

The landscape of bacteriological testing is being transformed by a series of converging trends that redefine workflows and competitive benchmarks. Advances in high-throughput sequencing and digital PCR are enabling laboratories to move beyond binary pathogen detection toward comprehensive genomic profiling. At the same time, emerging regulatory initiatives are mandating real-time reporting and traceability, prompting investment in cloud-enabled platforms and automated data management systems.

Furthermore, the drive for sustainability has introduced new imperatives, from eco-friendly reagent formulations to energy-efficient instrumentation. The COVID-19 pandemic underscored the importance of diagnostic agility, leading to the rapid adoption of point-of-care testing and decentralized sampling networks. Moving forward, artificial intelligence and machine learning applications promise to streamline data interpretation, while mobile diagnostics and remote monitoring solutions will extend testing capabilities into underserved regions. These collective shifts are forging a more connected, responsive, and intelligence-driven testing ecosystem.

Unraveling the 2025 US Tariff Effects on Laboratory Costs

The implementation of revised United States tariffs in 2025 has introduced significant cost pressures across reagent suppliers, instrument manufacturers, and end-user laboratories. Increased duties on imported culture media, PCR reagents, and high-precision instruments have cascaded through supply chains, prompting manufacturers to reassess sourcing strategies and adjust pricing models. As a result, laboratories are facing elevated per-test costs and extended procurement timelines.

In response, many providers are exploring near-shoring options and forging strategic partnerships with domestic suppliers to mitigate exposure to tariff volatility. Some have accelerated in-house manufacturing capabilities for critical consumables, while others are leveraging long-term contracts to stabilize pricing. Despite these proactive measures, the tariff impact is expected to persist through the next fiscal cycle, influencing capital expenditure decisions and driving demand for cost-effective, multipurpose diagnostic platforms. Organizations that proactively adapt their procurement and operational frameworks will be best positioned to maintain service continuity and safeguard margins.

Delineating Market Dynamics through Multidimensional Segmentation

A multidimensional segmentation framework reveals distinct growth drivers and competitive imperatives across applications, technologies, end users, sample types, and organism categories. In the application domain, clinical diagnostics demonstrates robust demand for in vitro diagnostics alongside a growing portfolio of laboratory developed tests and point-of-care formats. Environmental monitoring remains critical for air quality assessment and soil sampling initiatives, while food and beverage safety spans dairy, meat, and ready-to-eat product testing. Pharmaceutical and biotech workflows focus on both final product release assays and raw material verifications, whereas water testing priorities divide between drinking water compliance and wastewater surveillance.

Technological segmentation highlights the enduring relevance of automated culture testing and selective media even as immunoassays-encompassing enzyme linked immunosorbent formats and lateral flow devices-maintain broad appeal. Next generation sequencing is carving out a strategic niche through targeted and whole genome approaches, while polymerase chain reaction, in both digital and real-time configurations, underpins rapid, high-sensitivity detection. Rapid detection solutions, blending immunoassay and molecular principles, are catalyzing decentralized testing models.

Across end users, environmental agencies, food processors, hospital and diagnostic laboratories, pharmaceutical manufacturers, and water treatment plants each present unique procurement cycles and regulatory pressures. Sample type analysis underscores the pivot toward streamlined workflows for blood, urine, and water specimens, as well as high-throughput processing of food samples and surface swabs. Meanwhile, organism type segmentation-spanning bacteria, fungi, parasites, and viruses-emphasizes the need for adaptable platforms capable of multiplexed pathogen identification. This granular view of market structure empowers stakeholders to tailor offerings and prioritize investments with precision.

Regional Perspectives Driving Global Testing Trends

Regional dynamics continue to shape the strategic outlook for bacteriological testing providers and end-users alike. In the Americas, mature healthcare infrastructure and well-established regulatory frameworks drive sustained investment in advanced molecular diagnostics, while robust R&D ecosystems in the United States and Canada foster innovation. Latin American markets are distinguished by growing demand for cost-effective screening solutions and expanding public health surveillance programs.

The Europe, Middle East & Africa region presents a fragmented regulatory landscape that balances stringent EU directives with emerging markets in the Gulf and North Africa. Government funding for antimicrobial resistance initiatives and environmental monitoring is on the rise, prompting laboratories to expand capacity. In the Asia-Pacific, rapid urbanization, rising healthcare expenditures, and heightened food safety concerns are propelling growth. China, India, Japan, and Australia lead adoption of next-generation sequencing and point-of-care platforms, while Southeast Asian markets prioritize scalable, low-cost testing solutions to manage resource constraints.

Competitive Landscape and Strategic Positioning of Leading Providers

Leading providers in bacteriological testing are differentiating through technological integration, strategic collaborations, and geographic expansion. Major global players have enhanced their instrument portfolios by embedding digital analytics and connectivity, enabling real-time data sharing and remote diagnostics. Several firms have forged alliances with software vendors to offer cloud-based laboratory information management systems, thereby addressing end-to-end workflow optimization.

Investment patterns reveal a keen focus on molecular diagnostics as a high-growth segment, with significant R&D allocation toward next generation sequencing and digital PCR platforms. Meanwhile, established culture media and immunoassay suppliers are reinforcing their market positions by developing multiplexed assays and streamlined sample-to-answer solutions. Recent mergers and acquisitions underscore a trend toward consolidation, as companies seek to fill portfolio gaps and achieve scale economies. This competitive landscape demands continuous innovation, agile supply chains, and a customer-centric approach to deliver value across diverse testing scenarios.

Strategic Imperatives for Navigating a Transforming Market

Industry leaders should prioritize integration of advanced molecular platforms with automated sample preparation to drive both throughput and accuracy. Investing in flexible instrumentation that supports multiplexed assays will enable laboratories to address a broader spectrum of pathogens without compromising efficiency. Strengthening partnerships with reagent and consumable suppliers through long-term agreements can mitigate raw material cost fluctuations and ensure consistent supply under changing tariff regimes.

Geographic expansion into high-growth emerging markets requires tailored go-to-market strategies that account for local regulatory requirements and infrastructure constraints. Collaborating with regional agencies and academic institutions can accelerate validation cycles and build credibility. Additionally, embedding digital analytics and artificial intelligence within diagnostic workflows enhances data interpretation, predictive maintenance, and remote monitoring capabilities. By aligning product roadmaps with sustainability goals-such as reducing plastic waste and energy consumption-providers can meet both regulatory and corporate social responsibility objectives, while capturing value from an increasingly eco-conscious customer base.

Rigorous Research Framework Ensuring Analytical Integrity

This analysis is grounded in a comprehensive research methodology that balances qualitative insights with quantitative rigor. Secondary research encompassed a review of industry publications, regulatory filings, peer-reviewed journals, and financial disclosures. Primary research involved in-depth interviews with laboratory directors, procurement managers, R&D scientists, instrument suppliers, and regulatory experts. Survey data from a representative cross-section of end users supplemented expert interviews to validate market trends and technology adoption rates.

Data triangulation techniques were applied to reconcile discrepancies and enhance reliability, leveraging multiple data points for each key metric. An analytical framework was developed to segment the market by application, technology, end user, sample type, and organism classification, enabling layered insights. Key findings underwent peer review and expert validation to ensure objectivity and accuracy. This robust approach provides a solid foundation for strategic decision-making, equipping stakeholders with a clear, evidence-based view of market dynamics.

Synthesizing Insights for Informed Decision-Making

The global bacteriological testing sector stands at the intersection of technological innovation, regulatory evolution, and shifting cost structures. Understanding the nuances of tariff impacts, regional disparities, and competitive dynamics is essential for organizations seeking to optimize their testing capabilities and capitalize on emerging opportunities. Granular segmentation reveals pathways for targeted growth, while actionable strategic imperatives support resilience amid supply chain and regulatory challenges.

By synthesizing these insights, industry leaders can make informed decisions on platform investments, market entry strategies, and partnership development. The rigorously validated data and expert analyses contained in this report ensure a comprehensive picture of current realities and future trajectories. Equipped with this knowledge, decision-makers will be poised to drive innovation, improve operational performance, and maintain compliance in an increasingly complex diagnostic environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Clinical Diagnostics
      • In Vitro Diagnostics
      • Laboratory Developed Tests
      • Point Of Care Testing
    • Environmental Monitoring
      • Air Quality
      • Soil Sampling
    • Food And Beverage Safety
      • Dairy Products
      • Meat Products
      • Ready To Eat Products
    • Pharmaceutical And Biotech
      • Final Products
      • Raw Materials
    • Water Testing
      • Drinking Water
      • Wastewater
  • Technology
    • Culture Testing
      • Automated Systems
      • Selective Media
    • Immunoassay
      • Enzyme Linked Immunosorbent Assay
      • Lateral Flow Assay
    • Next Generation Sequencing
      • Targeted Sequencing
      • Whole Genome Sequencing
    • Polymerase Chain Reaction
      • Digital PCR
      • Real Time PCR
    • Rapid Detection
      • Rapid Immunoassay
      • Rapid Molecular
  • End User
    • Environmental Agencies
    • Food Processing Facilities
    • Hospitals And Diagnostic Laboratories
    • Pharmaceutical Manufacturers
    • Water Treatment Plants
  • Sample Type
    • Blood Samples
    • Food Samples
    • Surface Swabs
    • Urine Samples
    • Water Samples
  • Organism Type
    • Bacteria
    • Fungi
    • Parasites
    • Viruses
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bacteriological Testing Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.2.1. In Vitro Diagnostics
8.2.2. Laboratory Developed Tests
8.2.3. Point Of Care Testing
8.3. Environmental Monitoring
8.3.1. Air Quality
8.3.2. Soil Sampling
8.4. Food And Beverage Safety
8.4.1. Dairy Products
8.4.2. Meat Products
8.4.3. Ready To Eat Products
8.5. Pharmaceutical And Biotech
8.5.1. Final Products
8.5.2. Raw Materials
8.6. Water Testing
8.6.1. Drinking Water
8.6.2. Wastewater
9. Bacteriological Testing Market, by Technology
9.1. Introduction
9.2. Culture Testing
9.2.1. Automated Systems
9.2.2. Selective Media
9.3. Immunoassay
9.3.1. Enzyme Linked Immunosorbent Assay
9.3.2. Lateral Flow Assay
9.4. Next Generation Sequencing
9.4.1. Targeted Sequencing
9.4.2. Whole Genome Sequencing
9.5. Polymerase Chain Reaction
9.5.1. Digital PCR
9.5.2. Real Time PCR
9.6. Rapid Detection
9.6.1. Rapid Immunoassay
9.6.2. Rapid Molecular
10. Bacteriological Testing Market, by End User
10.1. Introduction
10.2. Environmental Agencies
10.3. Food Processing Facilities
10.4. Hospitals And Diagnostic Laboratories
10.5. Pharmaceutical Manufacturers
10.6. Water Treatment Plants
11. Bacteriological Testing Market, by Sample Type
11.1. Introduction
11.2. Blood Samples
11.3. Food Samples
11.4. Surface Swabs
11.5. Urine Samples
11.6. Water Samples
12. Bacteriological Testing Market, by Organism Type
12.1. Introduction
12.2. Bacteria
12.3. Fungi
12.4. Parasites
12.5. Viruses
13. Americas Bacteriological Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bacteriological Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bacteriological Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific, Inc.
16.3.2. Danaher Corporation
16.3.3. bioMérieux SA
16.3.4. F. Hoffmann-La Roche AG
16.3.5. Abbott Laboratories
16.3.6. Siemens Healthineers AG
16.3.7. QIAGEN N.V.
16.3.8. Becton, Dickinson and Company
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Merck KGaA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BACTERIOLOGICAL TESTING MARKET MULTI-CURRENCY
FIGURE 2. BACTERIOLOGICAL TESTING MARKET MULTI-LANGUAGE
FIGURE 3. BACTERIOLOGICAL TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BACTERIOLOGICAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BACTERIOLOGICAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BACTERIOLOGICAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PARASITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 101. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 102. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 103. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 104. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 105. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 107. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 108. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 109. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 110. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 111. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 190. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 193. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 194. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 195. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 196. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 198. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 199. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 200. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 201. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 202. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 208. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 209. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 210. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 211. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 213. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 214. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 215. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 216. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 217. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 235. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 237. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 238. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 239. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 240. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 241. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 243. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 244. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 245. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 246. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 247. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 249. ITALY BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 253. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 255. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 256. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 258. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 259. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 261. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 262. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SPAIN BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 310. DENMARK BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. DENMARK BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 312. DENMARK BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bacteriological Testing market report include:
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA

Table Information